An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
Description
The Omicron variant continuously evolves under the humoral immune pressure exerted by vaccination and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and the resulting Omicron subvariants display further immune evasion and
